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Deep learning algorithms 
out‑perform veterinary 
pathologists in detecting 
the mitotically most active tumor 
region
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Manual count of mitotic figures, which is determined in the tumor region with the highest mitotic 
activity, is a key parameter of most tumor grading schemes. it can be, however, strongly dependent 
on the area selection due to uneven mitotic figure distribution in the tumor section. We aimed to 
assess the question, how significantly the area selection could impact the mitotic count, which has a 
known high inter-rater disagreement. On a data set of 32 whole slide images of H&E-stained canine 
cutaneous mast cell tumor, fully annotated for mitotic figures, we asked eight veterinary pathologists 
(five board-certified, three in training) to select a field of interest for the mitotic count. To assess the 
potential difference on the mitotic count, we compared the mitotic count of the selected regions to 
the overall distribution on the slide. Additionally, we evaluated three deep learning‑based methods 
for the assessment of highest mitotic density: in one approach, the model would directly try to predict 
the mitotic count for the presented image patches as a regression task. the second method aims 
at deriving a segmentation mask for mitotic figures, which is then used to obtain a mitotic density. 
finally, we evaluated a two‑stage object‑detection pipeline based on state‑of‑the‑art architectures 
to identify individual mitotic figures. We found that the predictions by all models were, on average, 
better than those of the experts. the two‑stage object detector performed best and outperformed 
most of the human pathologists on the majority of tumor cases. the correlation between the 
predicted and the ground truth mitotic count was also best for this approach (0.963–0.979). Further, 
we found considerable differences in position selection between pathologists, which could partially 
explain the high variance that has been reported for the manual mitotic count. to achieve better inter‑
rater agreement, we propose to use a computer‑based area selection for support of the pathologist in 
the manual mitotic count.
Patients with tumors profit significantly from a targeted treatment, and a key to this is the assessment of prog-
nostic relevant  factors1. Cells undergoing cell division (mitotic figures) are an important histological parameter 
for this: It is widely accepted that the density of cells in mitosis state, the so-called mitotic activity, strongly cor-
relates with cell proliferation, which is amongst the most powerful predictors for biological tumor  behavior2. 
Consequentially, mitotic activity is a key parameter in the majority of tumor grading systems and provides 
meaningful information for treatment considerations in clinical  practice3,4.
For example, the scheme by Elston and Ellis, which is commonly used to assess human breast cancer, proposes 
the count of mitotic figures within ten standardized areas at 400× magnification (high power field, HPF), resulting 
open
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in the mitotic count. Prognosis is determined by the mitotic count being between 0–9, 10–19, and > 20 for a 
low, moderate, and high score with respect to malignancy of the  tumor3. The grading system by Kiupel et al. for 
the assessment of canine cutaneous mast cell tumors (CCMCT), a highly relevant hematopoietic tumor in dogs, 
requires at least seven mitotic figures per 10 HPF for the classification as high grade, i.e., more malignant,  tumor5.
Common to most grading schemes is the recommendation to count mitotic figures in the area with the high-
est mitotic density (‘hot spot’), which is suspected to be in a highly cellular area in the periphery of the tumor 
 section1,6,7. As has been long assumed by many experts, we have recently confirmed for the case of CCMCT that 
mitotic figures can have a patchy distribution throughout the tumor  section8. Tumor heterogeneity of the mitotic 
 count9,10 and another index for tumor cell proliferation (Ki67 immunohistochemistry)11 have also been proven 
for human breast cancer. Opposed to previous assumptions, proliferative hot spots are often not located in the 
periphery of the tumor  section8,12. Due to significant tumor heterogeneity and lack of reproducible area selection 
protocols, the selection of the area will be influenced by a subjective component and is additionally restricted 
by limited time in a diagnostic setting. Accurate spotting of mitotic figures requires high  magnifications7, which 
makes the selection of a relatively small, but most relevant field of interest from a large tumor section difficult 
for pathologists.
The count of mitotic figures is known to have low  reproducibility13,14. While a low inter-rater agreement of 
mitotic figures will be one reason for some variance in mitotic count between  experts13, the area selected for 
counting has certainly also a significant  influence10,15. The sparse distribution of mitoses is calling for an increase 
in the number of HPF to be counted  within14,16. Manual count of mitotic figures is, however, a tedious and labor-
intensive process, which puts a natural restriction on this number in a clinical diagnostic setting. Additionally, 
with an increasing number of HPF, the mitotic count (MC) will converge towards the average MC of the slide, 
which contradicts the idea of assessment in the most malignant area of the tumor, where the result is likely to 
have the greatest prognostic value. Although a proof of the higher prognostic value of tumor ’hot spots’ com-
pared to average counts have not been shown for the MC previously, recent studies have shown that hot spots 
of the proliferative immunohistochemical marker Ki67 is superior to enumerating entire tumor section or the 
tumor  periphery12,17.
While the time a pathologist can spend on region selection in a clinical setting is limited and thus only small 
parts of the tumor can be examined, algorithmic approaches can screen the complete whole slide images (WSI) 
for mitotic figures within a short time and independent from human interaction. To improve reproducibility and 
accuracy of the manual mitotic figure count, we thus propose to incorporate an automatic or semi-automatic 
preselection of the region of the highest mitotic count. This augmentation has the potential to improve prognostic 
value and reduce time effort for human prognostication at the same time.
In this work, we compared three convolutional neural network (CNN)-based approaches, and assessed their 
ability to estimate the area of highest mitotic activity on the slide. The main technical novelty of this work 
is the customization of three very different state-of-the-art deep learning methods, representing the tasks of 
segmentation, regression and detection, and their embedding into a pipeline tailoring for this task. On a data 
set of completely annotated WSI from CCMCT, we compared the algorithms performance against those of five 
board-certified veterinary pathologists and three veterinary pathologists in training. To the best of the authors’ 
knowledge, this is the first time that human expert were compared in such a task.
Related work
Mitotic figure detection is a known task in computer vision for more than three  decades18. It took until the advent 
of deep learning  technologies19, first used by Cireşan et al.20, for acceptable results to be achieved. The models 
used in this approach were commonly pixel classifiers trained with images where a mitotic figure is either at 
the center (positive sample) or not (negative sample). In recent years, significant advances were made in this 
field, also fostered by several competitions held on this  topic1,21,22. Especially the introduction of deeper residual 
 networks23 had a tremendous influence on current methods. One example of this is the DeepMitosis framework 
by Li et al.24. Their work combines a mitotic figure detection approach based on state-of-the-art object detec-
tion pipelines with a second-stage classification and shows that this second stage can significantly increase the 
performance for the task of mitotic figure classification.
Even though results, as achieved by Li et al. on the 2012 ICPR MITOS data  set21 with F1-scores of up to 
0.831, are impressive, the approaches will likely still not meet clinical requirements for a several reasons: Firstly, 
robustness to image variability increasing factors like changes in stain or image sharpness were not included 
in the data set, while this is common in whole slide images (WSI). This is especially true for the 2012 ICPR 
MITOS data set, where training and test images were extracted from the same  WSI21, and thus the test set does 
not fulfill the purpose of assessment of robustness. Further, only a small portion of the tumor was annotated 
in this data set (and also all other publicly available data sets). We can thus question the generalization of these 
results, since the data sets overestimate the prevalence of mitotic figures and specifically exclude structures that 
have a similar visual appearance to mitotic figures like cellular structures in necrotic tissue or artifacts from the 
excision boundary of the tumor.
Pati et al.25 have performed algorithmic assessments on the WSI of the  TUPAC1622 data set, which does, 
however, also not include mitotic figure annotations for locations outside the 10 high power field (HPF) region 
that was previously selected by a  pathologist1. To circumvent these limitations, Pati et al. employ an invasive 
tumor region mask generation to exclude tissue outside the main tumor in a semi-supervised approach. They 
introduce a mitotic density map as visualization and add a weighting factor that is inversely proportional to the 
distance to the tumor  boundary25. They were, however, due to the lack of annotation data, not able to verify 
these maps against some kind of ground truth. The weight given to the mitotic density map strongly relies on 
the assumption that the tumor border contains more actively metastatic cells than internal  regions25. While this 
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assumption is part of many MC protocols, there is no work known to the authors that provides a general proof for 
this, especially for a greater variance of tumor types. In fact, for the case of CCMCT, a previous  analysis8 showed 
no such relationship on the data set used in this  work26. Also Ki67 hot spots had been found in the periphery in 
only some cases of human breast  cancer12.
Material
Our research group built a data set consisting of 32 CCMCT cases, where all mitotic figures have been annotated 
within the entire tumor area. The data set, including a detailed description of its creation and anonymized forms 
of all WSI and all annotations, is available  publicly26. All tissue samples were taken retrospectively from the 
diagnostic archive of the authors with approval by the local governmental authorities (State Office of Health and 
Social Affairs of Berlin, Germany, approval ID: StN 011/20), and were originally provided from routine diagnostic 
service for purely diagnostic and therapeutic reasons, i.e. no animal was harmed for the construction of the data 
set or this study. All methods were performed in accordance with the relevant guidelines and regulations. Tissue 
section were routinely prepared and slides were stained with standard hematoxylin and eosin (H&E) dyes using 
a tissue stainer (ST5010 Autostainer XL, Leica, Germany), prior to being digitized using a linear scanner (Aperio 
ScanScope CS2, Leica Biosystems, Germany) at a resolution of 0.25µmpx .
Using a novel software  solution27, it was possible to build up a database that includes annotations for both true 
mitotic figures and look-alikes that might be hard to differentiate. The initial screening was performed twice by 
the first pathologist, who annotated unequivocal mitoses, possible mitosis, and similar structures. The second 
pathologist then provided an additional label for all annotated cells. For this, the second export did not know 
about the class of the cells, nor about the distribution of classes. This setup was chosen in order to limit the bias 
in the data set acquisition while at the same time providing a very high sensitivity for selecting the potential 
mitotic figures.
In a follow-up step, both experts were presented with disagreed cells and found a common consensus. In order 
to incorporate potentially missed mitotic figures, we employed an deep-learning based object-detection pipeline 
to find additional mitotic figure candidates, not being part of the data set before, which were subsequently also 
assessed by two pathologists with a final joint consensus. In this step, we used a low cutoff for the machine learn-
ing system to enable high sensitivity, leading to 89,597 candidates, which finally resulted in only 2273 mitotic 
figures confirmed by both pathologists. This procedure enabled the generation of a high-quality mitotic figure 
data set that is unprecedented in size to date, including a total of 44,880 mitotic figures and 27,965 non-mitotic 
cells with similar appearance to mitotic cells (hard negatives). The total tumor area in all 32 cases is 4939mm2 
( µ = 149.68mm2, σ = 96.99mm2).
This novel data set provides us, for the first time, with the possibility to assess the performance of algorithms 
for a region of interest prediction at a large scale. Using this data set, we can derive a (position-dependent) ground 
truth mitotic count (MC) by counting all mitotic figures in a window of 10 HPF size around the given position, 
and thus evaluate how the MC depends on the position used for counting. To perform cross-validation, we split 
up the slide set into three batches, where two would be used for training and validation (model selection), and 
one would serve as a test set.
An analysis of this data set underlines the assumption that the distribution of mitotic figures is not uniform 
but rather patchy (see Fig. 1), which further highlights the need for a proper selection of the HPFs for a repro-
ducible manual count.
Methods
In this work, our aim was to compare field-of-interest (FOI) detection for algorithmic approaches versus the 
manual selection by pathologists in CCMCT histological sections. We were unable to compare this on other 
publicly available data sets since no ground truth mitotic figure annotation data is available for the entire whole 
slide image.
pathology expert performance evaluation. To set a baseline for the task, we asked five board-certified 
veterinary pathologists (BCVP) and three veterinary pathologists in training (VPIT) to mark the region of inter-
5mm 5mm
5mm
Figure 1.  Distribution of mitotic count (count of mitotic figures per 10 HPF area), represented as a green 
overlay over the H&E-stained tumors from the CCMCT data set.
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est (spanning 10 HPF) which they would select for enumerating mitotic figures. The experts came from three 
different institutions. For this, we set no time limit, but pathologists were instructed to act as they would for rou-
tine diagnostics. Since the area of a single HPF is varying according to the optical properties of the microscope, 
we chose 2.37mm2 as the standard 10 HPF area as recommended by  Meuten7 at an aspect ratio of 4:3. While this 
area might not be sufficient for a stable classification, as shown by Bonert and  Tate16, it is currently the recom-
mended area size in veterinary pathology. From the 2.37mm2 area selected by the pathologist, we calculated the 
ground truth mitotic count, which was available with a two-expert-consensus from annotations in the data set.
General algorithmic approach. We compared three state-of-the-art methods, all aiming at the prediction 
of the mitotic count within a defined area of a histology slide. The first followed the indirect approach of predict-
ing a mitotic figure segmentation map, while the second tried to estimate the number of mitotic figures within 
an image directly, and the third tried to detect mitotic figures as objects using a pipeline inspired by the works of 
Li et al.24. For all methods, the original WSI was split up into a multitude of single images that were subsequently 
processed using the CNN. The result was concatenated to yield a scaled estimate for the mitotic density (see 
Fig. 2). All approaches were embedded into a toolchain where the estimator is followed by a concatenation and 
a 2D moving average (MA) operation. The filter kernel of this operation is in accordance with the width and 
height of the FOI (10 HPF). After the MA operator, the position of the maximum value within a valid mask V 
is determined as the center of the region of interest. The valid mask generation pipeline (lower branch of Fig. 2) 
performs a thresholding operation, followed by morphological closing. This gives a reasonable estimate of slide 
area filled by tissue. To exclude FOI predictions in border areas of the slide that are not to at least 95% covered 
by tissue, we perform an MA operator of the same dimensionality followed by a threshold of 0.95, yielding the 
valid mask V (see Fig. 2).
Estimation of mitotic figures via object detection. We took inspiration from the approaches by Li 
et al.24 and built a dual-stage object detection network for this task (see Fig. 3a). Over integrated dual-stage 
algorithms like Faster R-CNN29, this is only a minor additional computational effort (since the second stage 
is only processed for a detections by the first stage). The first stage is a customized RetinaNet-architecture30,31, 
incorporating a  ResNet1823 stem with feature pyramid network (FPN), of which we only used the layer with the 
highest resolution, and two customized heads (one for classification and one for position regression). The second 
stage is taking extracted cropped patches centered around a potential mitotic figure coordinate as an input and 
uses a standard ResNet18-based CNN classifier to perform a refined classification. As also described by Li et al. 
we found the second stage to increase performance  significantly26.
estimation of mitotic count using segmentation. While mitotic figure detection is usually consid-
ered an object detection task, where the position and the class probability of an object are estimated, we wanted 
to estimate a map of mitosis likelihoods for a given image. One approach that has been successfully used in a sig-
nificant number of segmentation tasks is the U-Net by Ronneberger et al.32. As previously shown, this approach 
can be utilized well for the given  task28. The target map for the network consists of filled circles of 50px diameter, 
wherever a mitotic figure was present (see Fig. 3b). We assume that this shape is a good estimate to represent the 
wide range of possible appearances a mitotic figure can have.
Regression of the mitotic figure count within an image patch. Direct estimation of the mitotic fig-
ure count is the most straight-forward way of deriving the area with the highest mitotic activity in the slide. We 
use a convolutional neural network with a single output value to regress the (normalized) mitotic count for each 
inference run. We based the network architecture of this approach on a ResNet50  stem23, to which we attached a 
new head consisting of a double layer of 3× 3× 128 convolutions and batch normalization, followed by a global 
average pooling layer (GAP) and a final 1× 1× 1 convolutional layer with sigmoid activation (see Fig. 3c).
To define the count of mitotic figures in an image, including partial mitotic figures in the border regions of the 
image (with width w and height h), we denote the x and y position of each mitotic figure in coordinates relative 
Figure 2.  Overview of the general framework. The CNN-based mitotic density estimator is applied to each WSI 
image patch. After the calculation, a moving window averaging operation yields mitotic density over the area of 
10 high power fields. Adapted  from28.
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to the image center as px and py , respectively. The approximated diameter of a mitotic figure is denoted d. The 
overall count, i.e., the target for the regression, is then defined as:
where the partial weight γ (x) in dependency of the positional offset is defined as:
The normalization parameter β was chosen heuristically as β = 10 . As loss function, we use the quadratic error 
( L2 ) for each image.
training and model selection. Besides the train-test split mentioned, we divided the training WSI into a 
training portion (upper 80% of the WSI) and a validation portion (remainder). For training, we used a sampling 
scheme that would draw images randomly from the slide, according to three group definitions: 
1. Images containing at least one mitotic figure.
2. Images containing at least one non-mitotic figure (hard negative example), as annotated by pathology experts.
3. Images randomly picked on a slide without any further conditions.
Each group of images had a dedicated justification of inclusion: While we included images with at least one 
mitotic figure for network convergence, the inclusion of hard negatives is well known in literature, although com-
monly in the form of hard example mining from the data  set22, which we, however, don’t need to employ since 
the data set provides these for our purpose. Finally, we include random picks to also train the network on the 
tissue where no mitotic figure can be expected. This is especially interesting for necrotic tissue, where nuclei can 
have a mitosis-like appearance and for cells near the excision boundary of the tumor. All images were randomly 
sampled from the training WSI using the criteria described above and were additionally rotated arbitrarily prior 
to cropping. Since WSI are typically very large (in the order of several Gigapixels), this resulted in a vast number 
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Figure 3.  Different mitotic figure density estimation approaches investigated in this work. (a) Dual-stage 
object detection pipeline based on a custom configuration of  RetinaNet31 and a ResNet-1823-based classifier. (b) 
Generation of a mitotic figure segmentation map using a U-Net32 network architecture, as described in Ref.28. 
(c) Estimation of mitotic density using a direct regression approach based on a ResNet-50 architecture.
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fed to the network. The training batch severely overestimates the a priori probability of a mitotic figure being 
present, but we found that this setup speeds up model convergence significantly. After around 1,500,000 single 
iterations, the models had typically converged. Even though the choice of images alleviates the heavily skewed 
distribution, the loss function still needs to be chosen appropriately to cater to imbalanced sets. For this reason, 
we used a negative intersection over union as  loss33 for the U-Net approach. L2 was used for the regression 
approach. We trained the model using the ADAM adaptation method in TensorFlow with an initial learning rate 
of 10−3 . For model selection, we used the model state, which yielded the highest F1-score during validation for 
the U-Net approach. The model with the least mean squared error in prediction was chosen for the regression 
approach. For the object detection-based approach, we used a modestly differing training scheme, which was 
already described in a previous  publication26.
experiments with animal tissue. All procedures performed in studies involving animals were in accord-
ance with the relevant guidelines and regulations of the institution at which the studies were conducted. No IRB 
approval was required for this study, since all animal tissue was acquired in routine diagnostic service and for 
purely diagnostic and therapeutic reasons. This work did not involve experiments with humans or human tissue.
Results
The comparison of the mitotic count (as per ground truth annotation) at the predicted and pathologist-selected 
positions shows considerable differences. For better visualization, the tumor cases have been grouped into clearly 
low grade (all possible counts with MC < 7 ), borderline mitotic count, and clearly high grade (more than 75% 
of the possible counts with MC ≧ 7 ), as in a previous  study8. The spread is most visible in the group of tumors 
with borderline MC (middle panel of Fig. 4). In this group, the maximum of the mitotic count (i.e. the MC at 
the most mitotically active region) is above 7, which is the threshold in Kiupel’s scheme, yet the 25th percentile 
of the distribution is below this threshold. Thus, by definition, all of these tumors are (at least considering MC 
as sole criteron) high-grade tumors, yet with a non-negligible risk for inappropriate region selection leading to 
potential underestimation of the  grade8. Thus, in this group, the area selection has a considerable impact on the 
mitotic count being above or below the threshold. This is most obvious for the cases 12–16, and 18, where at least 
one pathologist selected an area for grading that did not have an above-threshold mitotic count. Cases 2, 14, and 
Figure 4.  Results of field-of-interest selection with tumor cases grouped according to previous  work8. The box-
whisker-plots visualize the distribution of mitotic count as per ground truth from the annotations of the data 
set. Markers indicate mitotic count derived from the positions selected by the pathologists or the algorithms. 
Since finding the area of the absolute maximum mitotic count is the objective, higher values are better. Results 
shown are derived from areas selected by five board-certified veterinary pathologists (BCVP), three veterinary 
pathologists in training (VPIT) and the five algorithmic approaches (regression, segmentation, first stage object 
detector (OD-Stage1), second stage object detector (OD-Stage2) and ablated data set for second stage object 
detector (OD2-10HPF)). The red dotted line indicates the threshold as per Kiupel’s grading  scheme5.
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15 are also shown in detail in Fig. 5, highlighting the effect of the selection of different areas on the mitotic count. 
In three all cases, the pathologists picked regions of high cellularity, as recommended by the grading  scheme5, 
yet mitotic figures were not evenly spread in this tissue, leading to a large spread in mitotic count in all three 
cases. For case 14, the region of the highest mitotic count was not found by any of the pathologists, and regions 
selected contained at maximum half the number of mitotic figures compared to the maximum area identified 
by one of the algorithmic approaches. A two-way ANOVA revealed no significant difference between the group 
of board-certified veterinary pathologists (BCVP) and the group of veterinary pathologists in training (VPIT) 
( F = 0.1358 , p(F) = 0.7129 for being in the ’board-certified’ /’in-training’ group, F = 71.465 , p = 0.0000 for 
the tumor case). Considering the question of FOI-derived mitotic count being below or above threshold ( ≥ 7 , 
as per Kiupel’s  scheme5), we find a substantial agreement ( κ = 0.713 ) for the VPIT group and an almost perfect 
agreement ( κ = 0.822 ) for the BCVP group for the group of borderline cases, and a perfect agreement for all 
other cases. Both test were performed with python statsmodels package, version 0.10.1.
Algorithmic estimation of mitotic count. The number of mitotic figures varies strongly not only with 
the size of the region of interest but also with its position. We always used an area of 10 HPF ( 2.37mm2 ), as 
recommended by Kiupel et al. For the purpose of selecting the mitotically most active 10 HPF region, it is not of 
interest if the algorithmic approach over- or underestimates the likelihood of mitotic figures, as long as this over- 
or underestimation is consistent over the whole data set. As such, it is similar to a scaling factor or an offset. We 
expect, however, to have a high correlation between the mitotic count estimated and the ground truth mitotic 
count. For this reason, we chose to use the correlation coefficient as one measure to evaluate the approaches.
In general, we find high correlations of the predicted mitotic count by the algorithmic approaches (see 
Table 1). Of all the described approaches, clearly, the two-stage object detection pipeline shows the best perfor-
mance, with correlations between 0.963 and 0.979, depending on the cross-validation fold. We do not find big 
differences in the single-stage approaches (segmentation, mitotic count regression, and single-shot object detec-
tion) in this metric. These correlations also translate into generally good performance when trying to find the 
mitotically most active region on the complete whole slide images (Fig. 4). The group of algorithmic approaches 
is, on average, better than the pathologist group for every single case. Also from this evaluation, we find that the 
dual-stage object detection pipeline (indicated by a cyan cross) scores best, achieving highest mitotic count on 
16 out of 32 tumor cases (2–4, 8, 10, 12, 17, 19, 20, 22–23, 25, 28–31), and being outperformed by a pathologist 
only in five cases (1, 5, 11, 15, 26).
Figure 5.  Tumor cases 2 (left), 14 (middle), and 15 (right) with mitotic figures as green points. Markings 
indicate the selected area of interest. Different choices of the area by the pathologists led to substantial 
differences in the count of mitotic figures (based on ground truth mitotic count, GTMC) in that area.
Table 1.  Correlation coefficient between ground truth and estimated mitotic count on all evaluated models, 
data sets, and all folds of the cross-validation. We look for the position of the highest mitotic density. Thus 
correlation is a suitable measure to compare models, as scaling and additional factors have no influence in the 
subsequent argmax operation.
Method Full data set Ablation study
Cross-val Fold 1 Fold 2 Fold 3 Fold 1 Fold 2 Fold 3
Segmentation 0.925 0.947 0.963 – – –
MC Regression 0.924 0.935 0.948 – – –
Object detection, 1 stage 0.916 0.939 0.957 0.868 0.904 0.930
Object detection, 2 stage 0.963 0.971 0.979 0.897 0.924 0.944
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Ablation study on 10 HPF data set. All previously published data sets with  annotations21,22,34,35 on 
mitotic figures only considered an area selected by an expert pathologist, typically spanning 10 HPF. The 
TUPAC16 data set was the first to provide the complete WSI additionally, yet, without annotations outside the 
field of interest that was selected by the pathologist. Veta et al. state that the task of finding such a region of inter-
est for the mitotic count is certainly a task worth  automating1. Since our data set provides us with the possibility 
to assess algorithmic performance on this task, we asked ourselves the question of how much our best perform-
ing (two-stage) algorithmic pipeline would degrade if we trained it with a limited data set, also only spanning 10 
HPF. We aim to relate to the state-of-the-art in data sets with this methodology.
We find a significantly reduced correlation of the estimated mitotic count with ground truth data in this 
case (see Table 1), which also reflects in reduced performance, especially for the borderline tumor cases. For 
the example of case 14, we can see the influence of deteriorated tissue found at the excision boundary of this 
tumor section. While in the tissue border, there is a rather low number of true positives (cf. Fig. 6 left panel), we 
find a vast number of false positives related to cells with similar appearance than actual mitotic figures (Fig. 6 
top middle and bottom right panel), which is not present when trained on the full data set (Fig. 6 top right). 
The ablation study thus suggests that other regions (outside the FOI) are included in the training to allow for 
generalization to the whole WSI.
Discussion
Our results support the hypothesis that one significant reason for high rater disagreement in the mitotic count, 
which is well-known in human and veterinary pathology, lies in the selection of HPFs used for counting. On our 
data set, we found the distribution of mitoses to be fairly patchy, and selection of area does thus have a substantial 
impact on the mitotic count. This emphasizes the importance of this preselection task, which was not tackled in 
any mitosis detection challenge so far.
Our work also underlines that while pathologists will likely not be consistently able to select the area of high-
est mitotic activity (see Fig. 7), an algorithmic evaluation of the WSI could prove to be a good augmentation 
method. We have evaluated the tumor selection based on intratumoral heterogeneity within the same tumor 
section representing a single 2D-plane of the tumor, however, there may also be intratumoral heterogeneity at the 
3D-levels, as has been shown for human breast  cancer9. Whereas manual tumor screening is restricted a small 
number of tumor sections, automated or semi-automated analysis has the potential to significantly increase the 
number of evaluated tumor sections and thereby allowing a more extensive, systematic (stereological) sampling 
of the tumor biopsy. Besides finding the area of highest mitotic activity, the methods presented in this paper 
can also well serve as an aid to navigating the whole slide image and could thus generate further insights for a 
more precise prognosis.
Figure 6.  Ablation study on data set size, case 12. Ground truth (left), estimate by dual-stage object detection 
pipeline trained on reduced (top middle) or full (top right) data set. Annotations and detected mitotic figures 
by two-stage object detection pipelines are given as green dots in overview and as green rectangles in detail view 
(bottom right). Expert and model selections are given as rectangles spanning an area of 10 HPF.
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A limitation of current grading ambitions is the poor consistency of the applied grading methods between 
the different systems. Whereas most grading systems require a mitotic count in ten consecutive, non-overlapping 
HPF in the area with the highest mitotic  density3,4,6 other systems count mitotic figures in three  fields36 or propose 
a random selection of individual  HPF36,37. To the authors’ best knowledge, current literature does not imply which 
method has the best agreement with prognosis, and the most informative method and area could also be subject 
to the tumor type. In the present work, we have therefore decided to use the criteria of the respective grading 
system, i.e., ten consecutive HPF in the area within the highest density and a size of the HPF in consensus with 
current  guidelines7. A potential limitation is that we had to preset the aspect ratio of the FOI. We assume that 
while the actual shape of this area might play a role in an individual case, on average, the impact is negligible. 
The effect of this, however, will have to be investigated further for data sets where prognostic data is available. 
Another potential limitation of the work is that we evaluated deep learning-based approaches on a dataset that 
was also partially generated with the help of deep learning. The increase of mitotic figures by this augmentation, 
however, was only 5.3% (42,607 vs. 44,880), and additionally each mitotic figure candidate identified by the system 
was judged independently by two pathologists. We can thus assume that the potential bias of this augmentation 
stage on the results of this work is negligible.
Reproducibility is a crucial aspect of each diagnostic method, as also pointed out by  Meuten38. A clear defini-
tion of the criteria and methods used for counting, which is essential in this regard, should thus try to reduce 
individual factors as much as possible. As such, also a manual pseudo-random selection of areas should be 
questioned due to non-existent reproducibility. While the computer-aided methods may have limitations and 
not be error-proof, they can increase inter-rater concordance on average if they deliver better performance than 
the average human expert.
The non-existence of large-scale data sets of fully annotated whole slide tumor sections in many biomedical 
domains poses an important problem to fully algorithmic as well as to computer-aided diagnosis in this regard. 
Our study shows that there is a considerable potential for novel methods once such data sets also exist for other 
species and tissues. Our work also indicates that current data sets that feature only annotations for a very lim-
ited area within the slide might show severe limitations when algorithmic solutions shall be transformed into 
real applications within the pipeline of the pathologist. As suggested by our ablation study, results on current 
data sets might not be representative of entire tumor sections, and could even lead into wrong comparisons, as 
algorithmic increments could not translate into a real-world benefit. Given the importance of this task and the 
known rater disagreement, this should thus be a strong call for the creation of such data sets also on human tissue.
Current grading schemes were mostly developed in  retrospect3,4,38, with consideration of the survival rates 
of the patients and the manual mitotic count. Since the slides were not investigated for mitotic figures within 
the complete tumor area, the mitotically most active region was necessarily unknown and was possibly missed. 
Considering our findings, it is possible that those grading schemes have been based on false low MCs. Novel 
methods like those presented in this paper can thus help to develop more precise and reproducible grading 
schemes, which will then likely have adjusted thresholds.
Even though most grading schemes recommend the count of mitotic figures in the mitotically most active 
(hot spot) area, there is no general evidence that this leads necessarily to higher prognostic value. Bonert and 
 Tate16 and also Meyer et al.14 have called for an increase in area to achieve more meaningful cutoff values, which 
should improve reproducibility of the mitotic count. Using computer augmentation, an extension of the FOI may 
in fact become feasible for clinical routine. The sweet spot for prognostic value, however, is yet to be evaluated 
and likely also dependent on at least the tumor type. While taking the mean MC of the complete WSI would 
Figure 7.  Forest plots of the mitotic count (MC) derived from the region selected being above or equal to 
the upper half or upper 25%, respectively, of ground truth MC distribution comparing the main algorithmic 
approaches (regression, segmentation and object detection), the five board-certified veterinary pathologists 
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improve reproducibility of the MC, it is unclear if the prognostic accuracy would be improved by this apporach. 
Stålhammar et al. have recently shown for human breast cancer that hot spot tumor proliferation, based on the 
Ki-67 index, provide, in fact, a higher prognostic value than the tumor average or tumor  periphery17. This study, 
however, has yet to be confirmed, also for more tumor types. The methods proposed in this work can be utilized 
for such investigations on mitotic figures in H&E-stained slides.
While the advances by deep learning seem remarkable, we are aware that deep learning-based algorithms are 
neither traceable nor are they necessarily robust. This poses a major problem if applied in the field of medicine 
in general. To assure not only reliability, but also enable liability, it is important that each intermediate result of 
the pipeline can be verified by an expert.
In this regard, especially the object detection-based approach enables the pathologist to verify the detected 
mitotic figures, and thus observe if the machine learning system worked reliably. A computer + veterinarian 
solution (computer-assisted prognosis) thus yields the best overall combination of speed, accuracy and robust-
ness, at least for the short- to mid-term future.
Data availability
All code and data are available online at https ://githu b.com/maubr evill e/Mitos isReg ionOf Inter est.
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